• PhagoMed

PhagoMed advances to EIT Health catapult semi-finals

PhagoMed has been selected as a semi-finalist in the biotech track of the EIT Health Catapult, Europe’s premier Life Science competition. In June the company successfully competed at the regional finals for the DACH region (Germany, Austria, Switzerland) and was selected as one of two biotech companies to advance to the European stage of the competition. The semi-finals will take place in October 2020 and PhagoMed will compete with 13 other European biotechs for a spot in the European finals of the competition.

The EIT Health Catapult, currently in its fifth year of operation, is a training and competition programme that boosts the development of European health start-ups by exposing them to top quality experts and international investors. For more information on the competition on the European semi-finalists, please follow this link.